基本信息
views: 1
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Her research project (ESTREA: Exome Sequencing in stages of Treatment REsistance to Antidepressants) aims to study the contribution of rare and common genetic variants to the risk of developing treatment-resistant depression. The innovative features of this project are the study of rare variants obtained through whole exome sequencing in antidepressant response and the availability of data on the number and type of failed antidepressant treatments in each participant.
Before working at King’s College London, Chiara Fabbri graduated in medicine and surgery at Bologna University (Italy), where she also completed her clinical training in psychiatry and she started her research activity. Since she was a medical student, pharmacogenetics has been her main research interest, but she also contributed to the study of the clinical factors involved in the modulation of pharmacological treatment response in psychiatric disorders.
Chiara Fabbri obtained her PhD degree at Maastricht University, Department of Psychiatry and Neuropsychology (The Netherlands), with the thesis entitled: Pharmacogenomics of antidepressant drugs: perspectives for the personalization of treatment in depression.
Research interests:
Pharmacogenomics
Clinical-demographic modulators of response to psychotropic medications
Personalized treatment of psychiatric disorders
Genetics of mood disorders
Before working at King’s College London, Chiara Fabbri graduated in medicine and surgery at Bologna University (Italy), where she also completed her clinical training in psychiatry and she started her research activity. Since she was a medical student, pharmacogenetics has been her main research interest, but she also contributed to the study of the clinical factors involved in the modulation of pharmacological treatment response in psychiatric disorders.
Chiara Fabbri obtained her PhD degree at Maastricht University, Department of Psychiatry and Neuropsychology (The Netherlands), with the thesis entitled: Pharmacogenomics of antidepressant drugs: perspectives for the personalization of treatment in depression.
Research interests:
Pharmacogenomics
Clinical-demographic modulators of response to psychotropic medications
Personalized treatment of psychiatric disorders
Genetics of mood disorders
Research Interests
Papers共 268 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
NATURE GENETICSno. 5 (2024): 1-17
The Lancet Psychiatryno. 3 (2024): 210-220
medRxiv : the preprint server for health sciences (2024)
Lucie Bartova,Gernot Fugger,Markus Dold,Alexander Kautzky, Isabella Bairhuber, Philipp Kloimstein,Giuseppe Fanelli,Raffaella Zanardi,Ana Weidenauer,Dan Rujescu,Daniel Souery,Julien Mendlewicz,
Gianluca Borgiani,Chiara Possidente,Chiara Fabbri, Vincenzo Oliva,Mirjam Bloemendaal, Alejandro Arias Vasquez,Ted G Dinan,Eduard Vieta, Marco Menchetti,Diana De Ronchi,Alessandro Serretti,Giuseppe Fanelli
International clinical psychopharmacology (2024)
Neuroscience Appliedpp.104059, (2024)
medRxiv : the preprint server for health sciences (2023)
Neuroscience Applied (2023): 102958
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn